You are here: Home:  CCU 4 | 2004: Faculty disclosures


FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Robert A Wolff, MD Grants/Research Support: Eli Lilly and Company Consultant: Pfizer Inc Honorarium: Eli Lilly and Company, Pfizer Inc, Roche Laboratories Inc
Philip J Gold, MD Grants/Research Support: Pfizer Inc, Roche Laboratories Inc
George A Fisher, MD, PhD Grants/Research Support: AstraZeneca Pharmaceuticals LP Consultant: Bristol-Myers Squibb Company, Sanofi-Synthelabo Inc Honorarium: Bristol-Myers Squibb Company, Roche Laboratories Inc, Sanofi-Synthelabo Inc
Jean-Yves Douillard, MD, PhD Consultant: Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company Honorarium: AstraZeneca Pharmaceuticals LP, Roche Laboratories Inc, Sanofi-Synthelabo Inc

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

Table of Contents Top of Page

Home

Editor’s Note:
Polyp boy
 
Robert A Wolff, MD
- Select publications
 
Philip J Gold, MD
- Select publications
 
George A Fisher, MD, PhD
- Select publications
 
Jean-Yves Douillard, MD, PhD
- Select publications

Faculty Disclosures

A CME Audio Series
and Activity

Editor's office

 

Terms of use and general disclaimer
© Research To Practice, 2004. All rights reserved.